Largo Inc. completed a registered direct offering, selling 10.2 million common shares and warrants at $0.56 each, raising approximately $5.7 million. The warrants are exercisable immediately at $0.70 per share and expire in five years. Proceeds will be used for working capital, including paying trade creditors. Insiders, including the CEO and a major shareholder, participated under regulatory exemptions without affecting company control.
Largo Inc.'s recent US$5.7 million registered direct offering provides context for Pluang's Basic Materials sector snapshot. As of Sep 30, 2026 02:51 WIB, among 38 priced US stocks, 17 rose and 21 fell. Notably, Nucor Corporation (NUE) traded at USD 236.04 with a 3.46% decline and a typical hold time of 77 days, contrasting with Icl Group Ltd (ICL) which rose 3.19% to USD 5.18 and a 56-day hold time, while ArcelorMittal SA (MT) fell 2.81% to USD 67.89 with a 35-day hold time and 100% buy order activity on Pluang.
GameStop's CEO Ryan Cohen and other executives have made significant insider purchases of millions of shares, showing strong confidence in the company's future despite recent stock price volatility. These buys were active decisions, not pre-scheduled...
Concentrix Corporation reported mixed Q3 2026 results with earnings per share of $2.92, beating analyst expectations of $2.71. However, its revenue of $2.45 billion slightly missed the forecast of $2.48 billion. The company achieved a record free cas...
Accenture is set to report Q3 2026 earnings on October 1, with analysts forecasting $18.03 billion in revenue, a 5.6% increase year-over-year, and earnings per share around $3.18. The growth is fueled by strong demand for AI services, with 100 new ad...
Iovance Biotherapeutics shares jumped 31.48% after raising its 2026 revenue forecast, driven by strong demand for its cancer immunotherapy Amtagvi. SoundThinking's stock rose 50.09% following an acquisition agreement with Transom Capital Group, offer...
Shares of uniQure dropped 37.33% following mixed clinical data for its Huntington's disease gene therapy. Fair Isaac fell 26.52% after U.S. regulators expanded the use of competitor VantageScore in mortgage credit scoring, threatening its market posi...
